Open AccessTherapeutical Potential of Imines; Synthesis, Single Crystal Structure, Computational, Molecular Modeling, and ADMET Evaluation
Author(s) -
Diğdem Tatlιdil,
Muhammad Asam Raza,
Necmi Dege,
Ayşen Alaman Ağar,
Umme Farwa,
Shafiq ur Rehman
Publication year - 2022
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.2c00102
Subject(s) - chemistry , pharmacophore , supramolecular chemistry , orthorhombic crystal system , in silico , intermolecular force , single crystal , combinatorial chemistry , stereochemistry , crystal structure , computational chemistry , molecule , crystallography , organic chemistry , biochemistry , gene
Imines are multipurpose pharmacophores, simply accessible compounds, and have a broad range of usage in several areas of chemistry especially in medicine. Two novel compound imines, ( E )-4-methyl-2-(( o -tolylimino)methyl)phenol ( 1 ) and ( E )-2-(((4-methoxybenzyl)imino)methyl)-4-methylphenol ( 2 ), were synthesized with effective product via reported protocol in the literature. Single crystal X-ray diffraction (SCXRD) was employed for structural exposition, disclosing that both compounds are orthorhombic. To optimize the newly designed imines, a B3LYP functional with a basis set 6-31G(d,p) was mainly considered. DFT results were utilized to check correlation between the data recovered from SCXRD outcomes and also to measure the energy difference. Hirshfeld surface study was done to demonstrate the intermolecular contacts along the percentage of interaction in the overall crystalline compound. Molecular operating environment program was tested against AChE and BChE enzymes to perform a modeling study of the compounds. The docking score and binding affinity of the compounds revealed that 2 showed comparatively more inhibition than 1 . In silico ADMET studies exposed the physiochemical nature of these novel compounds, and it also unveiled that both compounds behaved as drug-like candidates.